(KR) Kroger - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5010441013
Stock:
Total Rating 38
Risk 80
Buy Signal -0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 23.8% |
| Relative Tail Risk | -6.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | 5.89 |
| Character TTM | |
|---|---|
| Beta | -0.067 |
| Beta Downside | 0.292 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.44% |
| CAGR/Max DD | 0.86 |
EPS (Earnings per Share)
Revenue
Description: KR Kroger
The Kroger Co. operates as a food and drug retailer in the United States. The company operates combination food and drug stores, multi-department stores, marketplace stores, and price impact warehouses. Its combination food and drug stores offer natural food and organic sections, pharmacies, general merchandise, pet centers, fresh seafood, and organic produce; and its multi-department stores provide apparel, home fashion and furnishings, outdoor living, electronics, automotive products, and toys. The company's marketplace stores offer full-service grocery, pharmacy, health and beauty care, and perishable goods, as well as general merchandise, including apparel, home goods, and toys; and its price impact warehouse stores provide grocery, and health and beauty care items, as well as meat, dairy, baked goods, and fresh produce items. It also manufactures and processes food products for sale in its supermarkets and online; and sells fuel through its fuel centers. The company sells its products through its stores, fuel centers, and online platforms. The Kroger Co. was founded in 1883 and is based in Cincinnati, Ohio.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 789.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: -1.51% < 20% (prev 5.84%; Δ -7.35% < -1%) |
| CFO/TA 0.12 > 3% & CFO 6.04b > Net Income 789.0m |
| Net Debt (21.24b) to EBITDA (5.29b): 4.01 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (655.0m) vs 12m ago -10.03% < -2% |
| Gross Margin: 22.70% > 18% (prev 0.23%; Δ 2247 % > 0.5%) |
| Asset Turnover: 258.6% > 50% (prev 240.1%; Δ 18.49% > 0%) |
| Interest Coverage Ratio: 2.05 > 6 (EBITDA TTM 5.29b / Interest Expense TTM 714.0m) |
Altman Z'' 2.37
| A: -0.04 (Total Current Assets 15.99b - Total Current Liabilities 18.22b) / Total Assets 51.44b |
| B: 0.55 (Retained Earnings 28.20b / Total Assets 51.44b) |
| C: 0.03 (EBIT TTM 1.47b / Avg Total Assets 56.93b) |
| D: 0.66 (Book Value of Equity 29.51b / Total Liabilities 44.40b) |
| Altman-Z'' Score: 2.37 = BBB |
Beneish M -2.98
| DSRI: 1.10 (Receivables 2.37b/2.19b, Revenue 147.22b/149.88b) |
| GMI: 1.00 (GM 22.70% / 22.62%) |
| AQI: 1.14 (AQ_t 0.09 / AQ_t-1 0.08) |
| SGI: 0.98 (Revenue 147.22b / 149.88b) |
| TATA: -0.10 (NI 789.0m - CFO 6.04b) / TA 51.44b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of KR shares?
As of February 28, 2026, the stock is trading at USD 68.24 with a total of 6,772,042 shares traded.
Over the past week, the price has changed by +2.83%, over one month by +10.42%, over three months by +1.94% and over the past year by +8.92%.
Over the past week, the price has changed by +2.83%, over one month by +10.42%, over three months by +1.94% and over the past year by +8.92%.
Is KR a buy, sell or hold?
Kroger has received a consensus analysts rating of 3.80.
Therefor, it is recommend to hold KR.
- StrongBuy: 9
- Buy: 3
- Hold: 12
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 73.5 | 7.7% |
| Analysts Target Price | 73.5 | 7.7% |
KR Fundamental Data Overview February 28, 2026
P/E Trailing = 59.4513
P/E Forward = 12.7551
P/S = 0.3024
P/B = 4.7377
P/EG = 1.442
Revenue TTM = 147.22b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 5.29b USD
Long Term Debt = 14.55b USD (from longTermDebt, last quarter)
Short Term Debt = 2.60b USD (from shortTermDebt, last quarter)
Debt = 25.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.24b USD (from netDebt column, last quarter)
Enterprise Value = 65.76b USD (44.52b + Debt 25.20b - CCE 3.96b)
Interest Coverage Ratio = 2.05 (Ebit TTM 1.47b / Interest Expense TTM 714.0m)
EV/FCF = 29.25x (Enterprise Value 65.76b / FCF TTM 2.25b)
FCF Yield = 3.42% (FCF TTM 2.25b / Enterprise Value 65.76b)
FCF Margin = 1.53% (FCF TTM 2.25b / Revenue TTM 147.22b)
Net Margin = 0.54% (Net Income TTM 789.0m / Revenue TTM 147.22b)
Gross Margin = 22.70% ((Revenue TTM 147.22b - Cost of Revenue TTM 113.81b) / Revenue TTM)
Gross Margin QoQ = 21.03% (prev 23.01%)
Tobins Q-Ratio = 1.28 (Enterprise Value 65.76b / Total Assets 51.44b)
Interest Expense / Debt = 0.58% (Interest Expense 146.0m / Debt 25.20b)
Taxrate = 20.05% (670.0m / 3.34b)
NOPAT = 1.17b (EBIT 1.47b * (1 - 20.05%))
Current Ratio = 0.88 (Total Current Assets 15.99b / Total Current Liabilities 18.22b)
Debt / Equity = 3.58 (Debt 25.20b / totalStockholderEquity, last quarter 7.04b)
Debt / EBITDA = 4.01 (Net Debt 21.24b / EBITDA 5.29b)
Debt / FCF = 9.45 (Net Debt 21.24b / FCF TTM 2.25b)
Total Stockholder Equity = 8.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 789.0m / Total Assets 51.44b)
RoE = 9.41% (Net Income TTM 789.0m / Total Stockholder Equity 8.38b)
RoCE = 6.39% (EBIT 1.47b / Capital Employed (Equity 8.38b + L.T.Debt 14.55b))
RoIC = 4.72% (NOPAT 1.17b / Invested Capital 24.82b)
WACC = 3.79% (E(44.52b)/V(69.72b) * Re(5.67%) + D(25.20b)/V(69.72b) * Rd(0.58%) * (1-Tc(0.20)))
Discount Rate = 5.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.95%
[DCF] Terminal Value 86.31% ; FCFF base≈2.23b ; Y1≈2.22b ; Y5≈2.34b
[DCF] Fair Price = 76.55 (EV 69.68b - Net Debt 21.24b = Equity 48.44b / Shares 632.8m; r=5.90% [WACC]; 5y FCF grow -0.92% → 2.90% )
EPS Correlation: -33.40 | EPS CAGR: -51.67% | SUE: -4.0 | # QB: 0
Revenue Correlation: -5.43 | Revenue CAGR: 0.65% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.69 | Chg7d=-0.001 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=15
EPS next Year (2027-01-31): EPS=5.29 | Chg7d=-0.008 | Chg30d=-0.012 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.3% (Discount Rate 7.9% - Earnings Yield 1.7%)
[Growth] Growth Spread = -4.7% (Analyst 1.6% - Implied 6.3%)
P/E Forward = 12.7551
P/S = 0.3024
P/B = 4.7377
P/EG = 1.442
Revenue TTM = 147.22b USD
EBIT TTM = 1.47b USD
EBITDA TTM = 5.29b USD
Long Term Debt = 14.55b USD (from longTermDebt, last quarter)
Short Term Debt = 2.60b USD (from shortTermDebt, last quarter)
Debt = 25.20b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 21.24b USD (from netDebt column, last quarter)
Enterprise Value = 65.76b USD (44.52b + Debt 25.20b - CCE 3.96b)
Interest Coverage Ratio = 2.05 (Ebit TTM 1.47b / Interest Expense TTM 714.0m)
EV/FCF = 29.25x (Enterprise Value 65.76b / FCF TTM 2.25b)
FCF Yield = 3.42% (FCF TTM 2.25b / Enterprise Value 65.76b)
FCF Margin = 1.53% (FCF TTM 2.25b / Revenue TTM 147.22b)
Net Margin = 0.54% (Net Income TTM 789.0m / Revenue TTM 147.22b)
Gross Margin = 22.70% ((Revenue TTM 147.22b - Cost of Revenue TTM 113.81b) / Revenue TTM)
Gross Margin QoQ = 21.03% (prev 23.01%)
Tobins Q-Ratio = 1.28 (Enterprise Value 65.76b / Total Assets 51.44b)
Interest Expense / Debt = 0.58% (Interest Expense 146.0m / Debt 25.20b)
Taxrate = 20.05% (670.0m / 3.34b)
NOPAT = 1.17b (EBIT 1.47b * (1 - 20.05%))
Current Ratio = 0.88 (Total Current Assets 15.99b / Total Current Liabilities 18.22b)
Debt / Equity = 3.58 (Debt 25.20b / totalStockholderEquity, last quarter 7.04b)
Debt / EBITDA = 4.01 (Net Debt 21.24b / EBITDA 5.29b)
Debt / FCF = 9.45 (Net Debt 21.24b / FCF TTM 2.25b)
Total Stockholder Equity = 8.38b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.39% (Net Income 789.0m / Total Assets 51.44b)
RoE = 9.41% (Net Income TTM 789.0m / Total Stockholder Equity 8.38b)
RoCE = 6.39% (EBIT 1.47b / Capital Employed (Equity 8.38b + L.T.Debt 14.55b))
RoIC = 4.72% (NOPAT 1.17b / Invested Capital 24.82b)
WACC = 3.79% (E(44.52b)/V(69.72b) * Re(5.67%) + D(25.20b)/V(69.72b) * Rd(0.58%) * (1-Tc(0.20)))
Discount Rate = 5.67% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -4.95%
[DCF] Terminal Value 86.31% ; FCFF base≈2.23b ; Y1≈2.22b ; Y5≈2.34b
[DCF] Fair Price = 76.55 (EV 69.68b - Net Debt 21.24b = Equity 48.44b / Shares 632.8m; r=5.90% [WACC]; 5y FCF grow -0.92% → 2.90% )
EPS Correlation: -33.40 | EPS CAGR: -51.67% | SUE: -4.0 | # QB: 0
Revenue Correlation: -5.43 | Revenue CAGR: 0.65% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.69 | Chg7d=-0.001 | Chg30d=+0.000 | Revisions Net=-1 | Analysts=15
EPS next Year (2027-01-31): EPS=5.29 | Chg7d=-0.008 | Chg30d=-0.012 | Revisions Net=-3 | Growth EPS=+10.2% | Growth Revenue=+1.9%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 6.3% (Discount Rate 7.9% - Earnings Yield 1.7%)
[Growth] Growth Spread = -4.7% (Analyst 1.6% - Implied 6.3%)